HUTCHMED (China) Limited
HCM · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $3 | $3 | $3 | $5 |
| - Cash | $1 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $3 | $3 | $5 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 0% | -14.4% | 0% | – |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | 39.7% | 39.7% | -17.4% | -17.4% |
| EBITDA | $0 | $0 | -$0 | -$0 |
| % Margin | 0.9% | 0.9% | -3.1% | -3.1% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 163.8% | 163.8% | 3.7% | 3.7% |
| EPS Diluted | 1.3 | 1.3 | 0.025 | 0.025 |
| % Growth | 0% | 5,100% | 0% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | $0 | $0 |